Cargando…
Heart Failure With Cardiogenic Shock as a Manifestation of Untreated POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, Skin Changes) Syndrome
POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, skin changes) is a rare paraneoplastic syndrome due to a plasma cell disorder. Diagnosis requires peripheral neuropathy and a monoclonal plasma cell disorder along with one major and one minor criteria, but cardiac man...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523341/ https://www.ncbi.nlm.nih.gov/pubmed/34692278 http://dx.doi.org/10.7759/cureus.18046 |
_version_ | 1784585281712685056 |
---|---|
author | Abdelahad, Mandi Pearson, Ryan Mauri, Bryant Fenton, Kira Savu, Cristina |
author_facet | Abdelahad, Mandi Pearson, Ryan Mauri, Bryant Fenton, Kira Savu, Cristina |
author_sort | Abdelahad, Mandi |
collection | PubMed |
description | POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, skin changes) is a rare paraneoplastic syndrome due to a plasma cell disorder. Diagnosis requires peripheral neuropathy and a monoclonal plasma cell disorder along with one major and one minor criteria, but cardiac manifestations are uncommon. The pathogenesis of POEMS syndrome is not well understood but it is thought to involve overproduction of proinflammatory cytokines, such as vascular endothelial growth factor (VEGF), interleukin-1 beta (IL-1B), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-alpha). POEMS syndrome commonly presents in the fifth to sixth decade of life, mainly in non-Hispanic Caucasian individuals, and affects more men than women (2:1). We report a unique case of a 28-year-old African American female with a history of POEMS syndrome and a new diagnosis of dilated, non-ischemic cardiomyopathy and New York Heart Association (NYHA) class IV, stage D heart failure with an ejection fraction (EF) of 30% as a result of the natural progression of her untreated POEMS syndrome. |
format | Online Article Text |
id | pubmed-8523341 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-85233412021-10-22 Heart Failure With Cardiogenic Shock as a Manifestation of Untreated POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, Skin Changes) Syndrome Abdelahad, Mandi Pearson, Ryan Mauri, Bryant Fenton, Kira Savu, Cristina Cureus Cardiology POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, skin changes) is a rare paraneoplastic syndrome due to a plasma cell disorder. Diagnosis requires peripheral neuropathy and a monoclonal plasma cell disorder along with one major and one minor criteria, but cardiac manifestations are uncommon. The pathogenesis of POEMS syndrome is not well understood but it is thought to involve overproduction of proinflammatory cytokines, such as vascular endothelial growth factor (VEGF), interleukin-1 beta (IL-1B), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-alpha). POEMS syndrome commonly presents in the fifth to sixth decade of life, mainly in non-Hispanic Caucasian individuals, and affects more men than women (2:1). We report a unique case of a 28-year-old African American female with a history of POEMS syndrome and a new diagnosis of dilated, non-ischemic cardiomyopathy and New York Heart Association (NYHA) class IV, stage D heart failure with an ejection fraction (EF) of 30% as a result of the natural progression of her untreated POEMS syndrome. Cureus 2021-09-17 /pmc/articles/PMC8523341/ /pubmed/34692278 http://dx.doi.org/10.7759/cureus.18046 Text en Copyright © 2021, Abdelahad et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Cardiology Abdelahad, Mandi Pearson, Ryan Mauri, Bryant Fenton, Kira Savu, Cristina Heart Failure With Cardiogenic Shock as a Manifestation of Untreated POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, Skin Changes) Syndrome |
title | Heart Failure With Cardiogenic Shock as a Manifestation of Untreated POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, Skin Changes) Syndrome |
title_full | Heart Failure With Cardiogenic Shock as a Manifestation of Untreated POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, Skin Changes) Syndrome |
title_fullStr | Heart Failure With Cardiogenic Shock as a Manifestation of Untreated POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, Skin Changes) Syndrome |
title_full_unstemmed | Heart Failure With Cardiogenic Shock as a Manifestation of Untreated POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, Skin Changes) Syndrome |
title_short | Heart Failure With Cardiogenic Shock as a Manifestation of Untreated POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, Skin Changes) Syndrome |
title_sort | heart failure with cardiogenic shock as a manifestation of untreated poems (polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, skin changes) syndrome |
topic | Cardiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523341/ https://www.ncbi.nlm.nih.gov/pubmed/34692278 http://dx.doi.org/10.7759/cureus.18046 |
work_keys_str_mv | AT abdelahadmandi heartfailurewithcardiogenicshockasamanifestationofuntreatedpoemspolyneuropathyorganomegalyendocrinopathymonoclonalproteinskinchangessyndrome AT pearsonryan heartfailurewithcardiogenicshockasamanifestationofuntreatedpoemspolyneuropathyorganomegalyendocrinopathymonoclonalproteinskinchangessyndrome AT mauribryant heartfailurewithcardiogenicshockasamanifestationofuntreatedpoemspolyneuropathyorganomegalyendocrinopathymonoclonalproteinskinchangessyndrome AT fentonkira heartfailurewithcardiogenicshockasamanifestationofuntreatedpoemspolyneuropathyorganomegalyendocrinopathymonoclonalproteinskinchangessyndrome AT savucristina heartfailurewithcardiogenicshockasamanifestationofuntreatedpoemspolyneuropathyorganomegalyendocrinopathymonoclonalproteinskinchangessyndrome |